Massey first in Richmond to offer cutting-edge therapy for metastatic prostate cancer
VCU Massey Cancer Center is the first cancer care provider in the Richmond metropolitan region to offer radium-223, an innovative, new drug that has been shown to increase survival and quality of life in patients with metastatic castration-resistant prostate cancer (CRPC). Radium-223 is given intravenously once a month for six months. The treatment is considered to be safe and manageable for both patients and providers and is covered by Medicare.
Massey’s new neuro-oncologist brings brain cancer expertise to the Richmond area
Mark G. Malkin, M.D., F.R.C.P.C., F.A.A.N., joins Virginia Commonwealth University (VCU) Massey Cancer Center as professor of neurology and the Richmond area’s only board-certified neuro-oncologist. Only 1 percent of neurologists in the country specialize in the treatment of neurological cancers, or neuro-oncology, and Malkin joins Asadulah Khan, M.D., assistant professor of pediatrics at Children’s Hospital of Richmond at VCU and Massey, as a fellowship-trained neuro-oncologist.
The importance of breast self-awareness in early detection
As part of their routine health care, women of all ages should be familiar with their bodies. Being aware of breast changes is especially important because many breast cancers are found by women themselves. To promote breast self-awareness, many advocacy groups encourage breast self-exams (BSE) on a routine basis. So, how do you properly perform a BSE and what should you look for?
Massey’s palliative care clinical director named a visionary in his field
Patrick Coyne, M.S.N., A.P.R.N., F.A.A.N., clinical director of the Palliative Care Program at VCU Massey Cancer Center, has been named one of the 30 most influential leaders in hospice and palliative medicine, the medical specialty focused on relieving suffering and improving quality of life for people with serious illnesses. Coyne was recognized as a visionary by his professional peers for his role in advancing hospice and palliative medicine.
Bacterial cells in the gut found to produce steroid hormones that could have implications for prostate and colon cancer
Recently, a team of VCU researchers, including VCU Massey Cancer Center researchers Gregory Buck, M.S., Ph.D., and Phillip Hylemon, Ph.D., member of Massey’s Cancer Cell Signaling research program, provided additional evidence that the bacteria found living inside the human gut may represent an endocrine organ. For example, the VCU team discovered that specialized gut bacterial cells produce steroid hormones – much like specialized cells in the pancreas produce the endocrine molecule insulin.